Evidence map›Paper›PMID 39844326›Full record

ArticleSubstance abuse treatment, prevention, and policy2025

Use of alternative payment models for substance use disorder prevention in the United States: development of a conceptual framework.

Elian Rosenfeld, Sarah Potter, Jennifer Caputo, Sushmita Shoma Ghose, Nelia Nadal, Christopher M Jones, Margaret R Kuklinski, Andrew D Carlo, D Max Crowley, Lisa Clemans-Cope and 1 more

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Substance abuse treatment, prevention, and policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Elian RosenfeldBehavioral Health and Health Policy, Westat, 1600 Research Blvd, Rockville, MD, 20850, USA. elianrosenfeld@westat.com.
Sarah PotterCenter for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration, Rockville, MD, USA.
Jennifer CaputoSocial Policy and Economics Research, Westat, Rockville, MD, USA.
Sushmita Shoma GhoseBehavioral Health and Health Policy, Westat, 1600 Research Blvd, Rockville, MD, 20850, USA.
Nelia NadalCenter for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration, Rockville, MD, USA.
Christopher M JonesCenter for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration, Rockville, MD, USA.
Margaret R KuklinskiSocial Development Research Group, School of Social Work, University of Washington, Seattle, WA, USA.
Andrew D CarloDepartment of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
D Max CrowleyHuman Development, Family Studies and Public Policy, Pennsylvania State University, University Park, PA, USA.
Lisa Clemans-CopeHealth Policy Center, Urban Institute, Washington, DC, USA.
Michael T FrenchDepartment of Health Management and Policy, University of Miami, Coral Gables, FL, USA.

Funding

Optimizing Prevention of Costly Adult OutcomesR01DA016903 · NIDA · DUKE UNIVERSITY · PI CROWLEY, DANIEL MAX, DODGE, KENNETH A · 2003 to 2019
$10.2M
Investing in Prevention Infrastructure: Economic Evaluation of the PROSPER SystemR01DA057996 · NIDA · PENNSYLVANIA STATE UNIVERSITY, THE · PI Daniel Max Crowley, DAMON JONES · 2023 to 2026
$2.7M
Strengthening Benefit-Cost Analyses of Substance Abuse PreventionF32DA034501 · NIDA · DUKE UNIVERSITY · PI CROWLEY, DANIEL MAX · 2012 to 2014
$150k
NIDA NIH HHS F32 DA034501NIDA NIH HHS R01 DA016903NIDA NIH HHS R01 DA057996
6 · The paper itself

Abstract

backgroundAlternative payment models (APMs) are methods through which insurers reimburse health care providers and are widely used to improve the quality and value of health care. While there is a growing movement to utilize APMs for substance use disorder (SUD) treatment services, they have rarely included SUD prevention strategies. Challenges to using APMs for SUD prevention include underdeveloped program outcome measures, inadequate SUD prevention funding, and lack of clarity regarding what prevention strategies might fit within the scope of APMs.

methodsIn November 2023, the Substance Abuse and Mental Health Services Administration (SAMHSA), through a contract with Westat, convened an expert panel to refine a preliminary conceptual framework developed for utilizing APMs for SUD prevention and to identify strategies to encourage their adoption.

resultsThe conceptual framework agreed upon by the panel provides expert consensus on how APMs could finance a variety of prevention programs across diverse populations and settings. Additional efforts are needed to accelerate the support for and adoption of APMs for SUD prevention, and the principles of health equity and community engagement should underpin these efforts. Opportunities to increase the use of APMs for SUD prevention include educating key groups, expanding and promoting the SUD prevention workforce, establishing funding for pilot studies, identifying evidence-based core components of SUD prevention, analyzing the cost effectiveness of APMs for SUD prevention, and aligning funding across federal agencies.

conclusionGiven that the use of APMs for SUD prevention is a new practice, additional research, education, and resources are needed. The conceptual framework and strategies generated by the expert panel offer a path for future research. SUD health care stakeholders should consider ways that SUD prevention can be effectively and equitably implemented within APMs.

Indexed as

Reimbursement MechanismsSubstance-Related DisordersHumansUnited StatesUnited States Substance Abuse and Mental Health Services AdministrationAlternative Payment ModelsConceptual FrameworkExpert PanelSubstance Use Disorder Prevention

Identifiers

PMID39844326
PMCPMC11752996

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.